4/1 2026
Pressure ulcers represent a significant healthcare challenge affecting patients with limited mobility. Understanding appropriate dressing selection for each NPIAP stage is crucial for optimizing healing outcomes and preventing complications — this guide provides evidence-based recommendations for procurement managers and clinical teams.
Pressure ulcers, also known as bedsores or decubitus ulcers, represent a significant healthcare challenge affecting patients with limited mobility. Understanding the appropriate dressing selection for each stage is crucial for optimizing healing outcomes and preventing complications. For a complete guide covering wound dressing types, specifications, and GCC procurement requirements, see our Wound Dressing Complete Buyer's Guide.
The National Pressure Injury Advisory Panel (NPIAP) developed a standardized staging system that has been widely adopted internationally. The current classification system uses Arabic numerals (Stage 1, 2, 3, 4) rather than Roman numerals and includes additional categories for injuries that cannot be fully assessed. According to research published in the Journal of Wound, Ostomy and Continence Nursing, this revision incorporates updated understanding of pressure injury etiology and clarifies anatomical features present at each stage.
Clinical Presentation: Intact skin with localized area of non-blanchable redness, typically over bony prominences. In darkly pigmented skin, may appear with persistent red, blue, or purple hues. The area may feel warmer, cooler, firmer, or softer compared to adjacent tissue.
Recommended dressing types:
Key Consideration: Stage 1 injuries are primarily managed through pressure relief and skin protection rather than wound healing dressings. Focus on prevention of progression to open wounds.
Clinical Presentation: Partial-thickness loss of skin with exposed dermis. The wound bed appears viable, pink or red, and moist. May present as an intact or ruptured serum-filled blister. Shallow open ulcer without slough.
Recommended dressing types:
For a full comparison of these wound dressing types including specifications and substitution rules, see our dedicated comparison guide.
Clinical Presentation: Full-thickness loss of skin where adipose tissue is visible. Granulation tissue and epibole (rolled wound edges) are often present. Slough and/or eschar may be visible. Depth varies by anatomical location. Undermining and tunneling may occur, but fascia, muscle, tendon, ligament, cartilage, and bone are not exposed.
Recommended dressing types:
Sequential Treatment Approach: Evidence from American Academy of Family Physicians demonstrates that sequential use of calcium alginate dressings (for debridement) followed by hydrocolloid dressings (for healing promotion) accelerates healing compared to hydrocolloid use alone.
Clinical Presentation: Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone. Slough and/or eschar may be visible. Epibole, undermining, and tunneling often occur.
Recommended dressing types:
Important Note: Stage 4 ulcers require comprehensive wound assessment and often multidisciplinary care. Surgical debridement may be necessary, and adequate vascularization must be confirmed before initiating aggressive healing protocols.
Clinical Presentation: Full-thickness skin and tissue loss where the extent of damage cannot be confirmed because it is obscured by slough or eschar. Once debrided, these injuries are typically reclassified as Stage 3 or Stage 4.
Recommended dressing types:
Exception: Per NPIAP guidelines, stable eschar (dry, adherent, intact without erythema or fluctuance) on the heel or ischemic limb should not be softened or removed.
| Dressing type | Absorption capacity | Best applications | Change frequency |
|---|---|---|---|
| Hydrocolloid | Low to moderate | Stage 2–3, light exudate, autolytic debridement | Every 3–7 days |
| Foam | Moderate to high | Stage 2–4, cushioning, moderate to heavy exudate | Every 3–5 days |
| Alginate | Very high | Stage 3–4, cavity filling, heavy exudate | Daily to every 2 days |
| Hydrogel | Low | Stage 2–4, dry wounds, necrotic tissue hydration | Every 1–3 days |
| Transparent film | None | Stage 1–2, prophylaxis, minimal exudate | Up to 7 days |
| Silver dressings | Varies by type | Infected or at-risk wounds, all stages | Per manufacturer guidelines |
According to American Family Physician guidelines, necrotic tissue must be removed for optimal healing. Debridement methods include:
Research consistently demonstrates that moist wound healing environments accelerate healing compared to dry conditions. A systematic review and network meta-analysis confirmed that moist dressings show superior performance in cure rates, healing time, and reduced dressing changes compared to traditional gauze dressings.
Deprecated Practice: Wet-to-dry dressings should only be used for debridement purposes, not as wound dressings. These cause pain and trauma by removing granulation tissue and new epithelial cells during changes.
Best Practice: Use advanced moisture-retentive dressings that maintain optimal wound hydration while managing exudate effectively. This approach reduces pain, protects fragile tissue, and accelerates healing.
When evaluating dressing products for institutional purchasing, consider total cost of care rather than unit price alone. For a complete sourcing guide covering dressing specifications and GCC procurement requirements, see our Wound Dressing Complete Buyer's Guide.
| Stage | Primary goal | First-line dressing | Alternative options |
|---|---|---|---|
| Stage 1 | Pressure relief & protection | Transparent film or thin hydrocolloid | Prophylactic silicone foam |
| Stage 2 | Moist healing environment | Hydrocolloid or foam | Hydrogel, transparent film |
| Stage 3 | Exudate management & healing | Foam or alginate (based on drainage) | Hydrocolloid, silver dressings |
| Stage 4 | Cavity filling & heavy exudate control | Alginate or hydrofiber | Foam, NPWT, silver dressings |
| Unstageable | Debridement to enable staging | Hydrogel or enzymatic agents | Hydrocolloid for autolytic debridement |
Kingphar supplies foam dressings, hydrocolloid dressings, island dressings, and transparent PU dressings — CE certified with full documentation for GCC, European, and North American procurement.
References: This article synthesizes information from the National Pressure Injury Advisory Panel (NPIAP), Journal of Wound Ostomy & Continence Nursing, Cochrane systematic reviews, NICE clinical guidelines, American Academy of Family Physicians, and current wound care research publications. All external sources are cited with hyperlinks throughout the document.
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoming Quality Inspection (IQI) for Medical Consumables: Complete Guide Procurement Quality ·
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoterms for Medical Supplies: FOB vs CIF vs DDP Explained (2026) Procurement
Kingphar Medical Group New’s 21/9 2026 No results See all results Table of Contents Inventory Management · Procurement Guide Medical ConsumablesShelf Life & ExpiryManagement Guide Shelf
Kingphar Medical Group New’s 31/8 2026 No results See all results Table of Contents Procurement Guide · Tender Writing How to Write Medical ConsumableTender SpecificationsThat Win
Kingphar Medical Group New’s 18/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical ConsumablesImport Documentation:The Complete Checklist A
Kingphar Medical Group New’s 7/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical Consumables HS Codes:Classification & ImportDuty
Cooperation, innovation and win-win
Don’t miss our future updates! Get Subscribed Today!
